REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Proavisol S.A.S. (Colombia)

Main Activities: Poultry and Egg Production
Full name: Proavisol S.A.S. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Proavisol S.A.S. is based in Colombia. The head office is in Bucaramanga. It operates in the Poultry and Egg Production industry. The company was established on September 27, 2016. It currently has a total number of 5 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 35.3% in 2024. There was a total growth of 69.61% in Proavisol S.A.S.’s total assets over the same period. In 2024, Proavisol S.A.S.’s net profit margin decreased by 4.23%.

Headquarters
Calle 63 D 3207 Local 7
Bucaramanga; Santander;

Contact Details: Purchase the Proavisol S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Proavisol S.A.S. report to view the information.
Registered Capital:
Purchase the Proavisol S.A.S. report to view the information.
Financial Auditors:
Purchase the Proavisol S.A.S. report to view the information.
Incorporation Date:
September 27, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Proavisol S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35.3%▲
Total operating revenue
32.45%▲
Operating profit (EBIT)
128.56%▲
EBITDA
95.8%▲
Net Profit (Loss) for the Period
-28.75%▼
Total Assets
69.61%▲
Total Equity
7.71%▲
Operating Profit Margin (ROS)
9.78%▲
Net Profit Margin
-4.23%▼
Return on Equity (ROE)
-3.66%▼
Debt/Equity
163.44%▲
Quick Ratio
0.35%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo